Specifically, GPX2 downregulation is contrasting because it has been reported as a regulator of EMT markers, enhancing invasion, and metastasis targeting the Wnt pathway in cervical and pancreatic cancer (26, 30). Here, GPX2 is linked to familial pancreatic carcinoma.